The IPO of Modern Diagnostic & Research Centre, a well-known diagnostics company, opens for subscription today.
This is the final IPO of 2025, giving investors one last opportunity to participate before the year ends.
The issue will remain open until January 2, 2026.
Contents
Modern Diagnostic IPO: Key Details
This IPO is a book-built issue.
The company aims to raise ₹36.89 crore by issuing 0.41 crore fresh shares.
There is no offer-for-sale (OFS) component, which means all the money raised will go directly to the company.
The IPO price band has been fixed at ₹85 to ₹90 per share.
Shares will be listed on the BSE SME platform on January 7, 2026.
GMP Explained: What Listing Gains Can Investors Expect?
According to InvestorGain, Modern Diagnostic shares were trading at a premium of ₹10 in the grey market on December 31.
Based on the upper price band of ₹90, the estimated listing price is around ₹100 per share.
This suggests a possible listing gain of about 11.11%.
However, investors should remember that GMP is not official.
It changes frequently and does not guarantee profit or loss on listing day.
Lot Size and Investment Required
One lot of the IPO includes 1,600 shares.
Retail investors must apply for at least two lots, or 3,200 shares.
This requires an investment of ₹2.88 lakh at the upper price band.
HNI investors need to apply for a minimum of three lots, or 4,800 shares, which means an investment of ₹4.32 lakh.
Important IPO Dates to Remember
IPO opens: December 31, 2025
IPO closes: January 2, 2026
Share allotment: January 5, 2026
Refunds initiated: January 6, 2026
Shares credited to demat account: January 6, 2026
Listing on BSE SME: January 7, 2026
About the Company
Modern Diagnostic & Research Centre is a growing diagnostic chain in India.
It offers pathology and radiology services, including diagnostic tests, home sample collection, online reports, and customized test packages.
The company currently operates 21 centers across eight states, with 18 laboratories and three diagnostic centers serving both individual patients and institutional clients.
Disclaimer
This information is provided for general awareness only.
Investing in the stock market involves risk.
Investors are advised to consult a financial expert before making any investment decisions.